Prostate Cancer UK
Tim Windle is the Policy Manager at Prostate Cancer UK where he has led the charity’s work on access to treatments for the past two and half years. He has been a member of NHSE England’s Chemotherapy Clinical Reference Group which oversees the commissioning of cancer medicines in the NHS. He is also part of a number of charity groups including the Charity Medicines Access Coalition and Access to Cancer Medicines Coalition. He previously worked at The Association of the British Pharmaceutical Industry, the trade body for branded pharmaceutical companies in the UK.
Why research isn’t enough for patient access: the technology appraisal process
This session will explore what happens after research publishes and a medicine is licensed. It will seek to highlight some of the challenges and difficulties which mean it can be years before patients are able to access treatments outside private care. It will focus on a particular case study in England and consider what this might mean for translating the future research pipeline into practice.
EVEN MORE SEMINARS
Dr Penny Kechagioglou GenesisCare UK
Breast cancer Service of the Future: a service transformation
Nicky Robinson Penny Brohn UK
Food as Medicine: Diet and Nutrition in Cancer Care
Dr Shanmugasundaram Ramkumar University Hospital Southampton NHS Foundation Trust
Radiotherapy developments in management of recurrent rectal cancers
Dr Catherine Coyle Christie Hospital NHS Foundation Trust
Prostate Cancer- the non surgical oncologists view
Dr. Konstantinos Vougas DeepMed IO Ltd
AI in decision support of diagnostic and personalised medicine applications.